Expression of the Glucose Transporter GLUT12 in Alzheimer's Disease Patients

Journal of Alzheimer's Disease

Volumn 42, Issue 1, 2014, Pages 97-101

  Pujol Gimenez, Jonai ^a   Martisova, Eva ^b   Perez Mediavilla, Alberto ^b   Lostao, María Pilar ^a   Ramirez, Maria J ^a,b  

^a UNIVERSITY OF NAVARRA   (Spain)

^b UNIVERSITY OF NAVARRA   (Spain)

Author keywords

Frontal cortex; glucose transport; microglia; western blot

Indexed keywords

GLUCOSE TRANSPORTER; GLUCOSE TRANSPORTER 12; UNCLASSIFIED DRUG; CD11B ANTIGEN; ITGAM PROTEIN, HUMAN; SLC2A12 PROTEIN, HUMAN;

AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DONOR; DOWN REGULATION; FEMALE; FRONTAL CORTEX; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MICROGLIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION; ADULT; AGING; FRONTAL LOBE; METABOLISM; VERY ELDERLY; WESTERN BLOTTING;

ADULT; AGED; AGED, 80 AND OVER; AGING; ALZHEIMER DISEASE; ANTIGENS, CD11B; BLOTTING, WESTERN; FEMALE; FRONTAL LOBE; GLUCOSE TRANSPORT PROTEINS, FACILITATIVE; HUMANS; MALE; MICROGLIA;

EID: 84919646946     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-132498     Document Type: Article

References (18)

1. de la Monte SM(2012) Brain insulin resistance and deficiency as therapeutic targets in Alzheimer's disease. Curr Alzheimer Res 9, 35-66.
2. De Felice FG (2013) Alzheimer's disease and insulin resistance: Translating basic science into clinical applications. J Clin Invest 123, 531-539.
3. Simpson IA, Carruthers A, Vannucci SJ (2007) Supply and demand in cerebral energy metabolism: The role of nutrient transporters. J Cereb Blood Flow Metab 27, 1766-1791.
4. Pujol-Giménez J, Barrenetxe J, González-Muniesa P, Lostao MP (2013) The facilitative glucose transporter GLUT12: What do we know and what would we like to know? J Physiol Biochem 69, 325-333.
5. Rogers S, Macheda ML, Docherty SE, Carty MD, Henderson MA, Soeller WC, Gibbs EM, James DE, Best JD (2002) Identification of a novel glucose transporter-like protein- GLUT-12. Am J Physiol Endocrinol Metab 282, E733-E738.
6. Waller AP, Kohler K, Burns TA, Mudge MC, Belknap JK, Lacombe VA(2011) Naturally occurring compensated insulin resistance selectively alters glucose transporters in visceral and subcutaneous adipose tissues without change in AS160 activation. Biochim Biophys Acta 1812, 1098-1103.
7. Uldry M, Thorens B (2004) The SLC2 family of facilitated hexose and polyol transporters. Pflugers Arch 447, 480-489.
8. Liu Y, Liu F, Iqbal K, Grundke-Iqbal I, Gong CX (2008) Decreased glucose transporters correlate to abnormal hyperphosphorylation of tau in Alzheimer disease. FEBS Lett 582, 359-364.
9. Lewis DA (2002) The human brain revisited: Opportunities and challenges in postmortem studies of psychiatric disorders. Neuropsychopharmacol 26, 143-154.
10. De Zutter JK, Levine KB, Deng D, Carruthers A (2013) Sequence determinants of GLUT1 oligomerization - analysisby homology-scanning mutagenesis. J Biol Chem 288, 20734-20744.
11. Stuart CA, Howell ME, Zhang Y, Yin D (2009) Insulinstimulated translocation of glucose transporter (GLUT) 12 parallels that of GLUT4 in normal muscle. J Clin Endocrinol Metab 94, 3535-3542.
12. Purcell SH, Aerni-Flessner LB, Willcockson AR, Diggs- Andrews KA, Fisher SJ, Moley KH (2011) Improved insulin sensitivity by GLUT12 overexpression in mice. Diabetes 60, 1478-1482.
13. Zawacka-Pankau J, Grinkevich VV, Hünten S, Nikulenkov F, Gluch A, Li H, Enge M, Kel A, Selivanova G (2011) Inhibition of glycolytic enzymes mediated by pharmacologically activated p53: TargetingWarburg effect to fight cancer. J Biol Chem 286, 41600-41615.
14. Cunnane S, Nugent S, Roy M, Courchesne-Loyer A, Croteau E, Tremblay S, Castellano A, Pifferi F, Bocti C, Paquet N, Begdouri H, Bentourkia M, Turcotte E, Allard M, Barberger- Gateau P, Fulop T, Rapoport SI (2011) Brain fuel metabolism, aging, and Alzheimer'sdisease. Nutrition 27, 3-20.
15. Redjems-Bennani N, Jeandel C, Lefebvre E, Blain H, Vidailhet M, Gueant JL (1998) Abnormal substrate levels that depend upon mitochondrial function in cerebrospinal fluid from Alzheimer patients. Gerontology 44, 300-304.
16. Xiang Y, Xu G, Weigel-Van Aken KA (2010) Lactic acid induces aberrant amyloid precursor protein processing by promoting its interaction with endoplasmic reticulum chaperone proteins. PLoS One 5, e13820.
17. Evans A, Bates V, Troy H, Hewitt S, Holbeck S, Chung YL, Phillips R, Stubbs M, Griffiths J, Airley R (2008) Glut-1 as a therapeutic target: Increased chemoresistance and HIF-1-independent link with cell turnover is revealed through COMPARE analysis and metabolomic studies. Cancer Chemother Pharmacol 61, 377-393.
18. Liu P, Lu Y, Gao X, Liu R, Zhang-Negrerie D, Shi Y, Wang Y, Wang S, Gao Q (2013) Highly water-soluble platinum(II) complexes asGLUTsubstrates for targeted therapy: Improved anticancer efficacy and transporter-mediated cytotoxic properties. Chem Commun 49, 2421-2423.